Acne Epidemiology Forecast 2026-2035

Read more about this report - Request a Free Sample

Acne Epidemiology Forecast Report Coverage

Expert Market Research's “Acne Epidemiology Forecast Report 2026-2035” offers comprehensive information on the prevalence and demographics of acne. It projects the future incidence and prevalence rates of acne cases across various populations. The study covers age, gender, and type as major determinants of the acne population. The report highlights patterns in the prevalence of acne over time and projects future trends based on multiple variables.

Acne Understanding: Disease Overview

Acne is a common and chronic inflammatory skin condition that is most prevalent during adolescence but can occur at any age. It typically occurs as pimples, whiteheads, blackheads, and cysts. In severe cases, acne can cause permanent scarring. Hormonal changes, genetics, stress, and certain medications, among others, can contribute to the development or worsening of acne. The condition can be effectively managed with the right combination of treatments and lifestyle adjustments.

Depending on the severity, acne can be classified as mild (mostly comedones), moderate (a mix of comedones, papules, and pustules), and severe (nodules, cysts, and potential for scarring). Acne diagnosis is usually clinical, based on the appearance and distribution of lesions, often on the face, back, and chest.

Acne Epidemiology Perspective

The acne epidemiology division offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. Expert Market Research provides both current and predicted trends for the acne epidemiology scenario by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for acne and their trends. The acne detailed epidemiology segmentation is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

• Acne is a common skin condition observed among adolescents and young adults, with the prevalence rates ranging between 35% to more than 90% among adolescents.
• It is reported that the onset of acne vulgaris can be as early as ages 7 to 12 , which typically resolves by the third decade of the person’s life. Further, around 20% of the affected people develop severe acne, which leads to scarring.
• Body dysmorphic disorder (BDD) has been identified in nearly 17% of individuals  with acne, with the risk of developing this psychiatric condition being approximately 7 times higher than in those without acne, as per a 2022 cross-sectional study.
• Studies show that urban populations  are more prone to be affected by acne as compared to rural populations. The prevalence and severity of acne vulgaris may also vary in certain racial and ethnic groups.

Age-Based Acne Epidemiology Insights

It is estimated that about 85% of individuals aged between 12 and 24 are affected by at least minor acne, according to the American Academy of Dermatology (AAD). This high prevalence is primarily due to hormonal changes that occur during puberty, which lead to increased sebum (oil) production, making the skin more prone to clogged pores and inflammation. Acne may persist into an individual’s 30s and 40s, with adult acne reported to occur in up to 15% of women.

Gender-Based Acne Epidemiology Insights

A 2020 cross-sectional study over one year assessed 77 patients with post-adolescent acne, with 27.3% males and 72.7% females. Acne prevalence was estimated to be 15.5% in males and 19.3% in females. The median age was 28 years for males and 31 years for females. Females mostly had mixed lesions, while males showed mainly non-inflammatory lesions. The study highlights that post-adolescent acne is more common in women and presents differently between genders.

Read more about this report - Request a Free Sample

Country-wise Acne Epidemiology Segment

The acne epidemiology data and findings for the United States, EU-4 (Germany, Spain, Italy, France), the United Kingdom, Japan, and India are also provided in the epidemiology section. 

The epidemiology of acne varies between countries owing to differences in factors such as genetic predisposition, hormonal profiles, dietary habits, stress levels, and lifestyle patterns, among others. In the United States, acne is the most common skin condition and affects nearly 50 million Americans  each year.

Acne: Treatment Overview

Treatment of acne depends primarily on the severity of the acne, the patient's age, and skin type. Topical agents such as retinoids (like tretinoin, adapalene, and tazarotene) are commonly used to promote cell turnover and prevent the formation of new acne lesions. Benzoyl peroxide helps in reducing inflammation and is effective against acne-causing bacteria.

Oral acne therapeutics, including antibiotics and isotretinoin, are also prescribed for the treatment of acne vulgaris. In females, hormonal therapies like combined oral contraceptives or anti-androgens (spironolactone) can be effective, especially when acne is linked to hormonal imbalances.

Key Questions Answered

• What are the key findings of acne epidemiology in the 8 major markets?
• What will be the total number of patients with acne across the 8 major markets during the forecast period?
• What was the country-wise acne epidemiology scenario in the 8 major markets in the historical period?
• Which country will have the highest number of acne patients during the forecast period of 2026-2035?
• Which key factors would influence the shift in the patient population of acne during the forecast period of 2026-2035?
• What are the currently available treatments in the acne market?
• What are the disease risks, signs, symptoms, and unmet needs of acne?

Scope of the Acne Epidemiology Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of acne based on several factors.
• Acne Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The acne report helps to identify the patient population and the unmet needs are highlighted along with an assessment of the disease's risk and burden.

Related Reports

Acne Treatment Market

Acne Therapeutics Market

Severe Acne Vulgaris Treatment Market